Viva Biotech Holdings (VBIZF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 7.44 Billion CNY | -5.95% |
| 2022 | 7.92 Billion CNY | -1.54% |
| 2021 | 8.04 Billion CNY | -1.34% |
| 2020 | 8.15 Billion CNY | 329.44% |
| 2019 | 1.89 Billion CNY | 258.71% |
| 2018 | 529.33 Million CNY | 161.53% |
| 2017 | 202.4 Million CNY | 98.78% |
| 2016 | 101.82 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 7.18 Billion CNY | 0.0% |
| 2024 Q1 | 7.18 Billion CNY | -3.62% |
| 2023 FY | 7.44 Billion CNY | -5.95% |
| 2023 Q1 | 8.14 Billion CNY | 2.86% |
| 2023 Q4 | 7.44 Billion CNY | 0.0% |
| 2023 Q3 | 7.44 Billion CNY | -8.56% |
| 2023 Q2 | 8.14 Billion CNY | 0.0% |
| 2022 Q4 | 7.92 Billion CNY | 0.0% |
| 2022 FY | 7.92 Billion CNY | -1.54% |
| 2022 Q3 | 7.92 Billion CNY | -2.84% |
| 2022 Q2 | 8.15 Billion CNY | 0.0% |
| 2022 Q1 | 8.15 Billion CNY | 1.34% |
| 2021 Q1 | 7.9 Billion CNY | -3.05% |
| 2021 Q3 | 8.04 Billion CNY | 1.76% |
| 2021 Q4 | 8.04 Billion CNY | 0.0% |
| 2021 FY | 8.04 Billion CNY | -1.34% |
| 2021 Q2 | 7.9 Billion CNY | 0.0% |
| 2020 Q3 | 8.15 Billion CNY | 147.24% |
| 2020 FY | 8.15 Billion CNY | 329.44% |
| 2020 Q1 | 3.29 Billion CNY | 73.69% |
| 2020 Q4 | 8.15 Billion CNY | 0.0% |
| 2020 Q2 | 3.29 Billion CNY | 0.0% |
| 2019 Q3 | 1.89 Billion CNY | 4.8% |
| 2019 Q1 | 1.81 Billion CNY | 242.29% |
| 2019 FY | 1.89 Billion CNY | 258.71% |
| 2019 Q4 | 1.89 Billion CNY | 0.0% |
| 2019 Q2 | 1.81 Billion CNY | 0.0% |
| 2018 FY | 529.33 Million CNY | 161.53% |
| 2018 Q3 | 529.33 Million CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 Q4 | 529.33 Million CNY | 0.0% |
| 2017 FY | 202.4 Million CNY | 98.78% |
| 2016 FY | 101.82 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 52.7 Million USD | -14036.187% |
| Skye Bioscience, Inc. | 11.94 Million USD | -62292.425% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | -5621.426% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -1349228.407% |
| Qrons Inc. | 420.00 USD | -1773788471.429% |
| Adynxx, Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 14.56 Million USD | -51065.955% |
| CSL Limited | 38.02 Billion USD | 80.406% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -70488.516% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -380349.078% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -2106674.278% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -26560.149% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -1550166.045% |
| Rebus Holdings, Inc. | 5000.00 USD | -148998140.0% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -322506912.987% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -966612.516% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -1083545.631% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -19077.574% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -103087.778% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -9756968.392% |
| SQZ Biotechnologies Company | 107.18 Million USD | -6850.388% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -520133.626% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -10294810.523% |
| Mesoblast Limited | 667.9 Million USD | -1015.422% |
| Marizyme, Inc. | 22.01 Million USD | -33740.048% |
| Genus plc | 1.02 Billion USD | -624.066% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -548351.838% |
| Pharming Group N.V. | 462.85 Million USD | -1509.56% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -224768.247% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -1492751.661% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -1188083.732% |
| ContraFect Corporation | 20.67 Million USD | -35926.462% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -1908342.846% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -1949235.517% |
| IMV Inc. | 31.33 Million USD | -23675.971% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -179588.193% |
| MultiCell Technologies, Inc. | 126.22 USD | -5902322828.221% |
| ONE Bio Corp. | 70.08 Million USD | -10529.747% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -792706.131% |
| RVL Pharmaceuticals plc | 128.51 Million USD | -5697.146% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -1725559.117% |
| Q BioMed Inc. | 3.51 Million USD | -211815.118% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -21077.157% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -2851246.272% |
| Biomind Labs Inc. | 73.81 Thousand USD | -10092033.462% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | -1569.228% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -514097.328% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -24720.669% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -271167.416% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -286083.292% |
| GB Sciences, Inc. | 103.44 Thousand USD | -7201918.522% |
| Alpha Cognition Inc. | 2.45 Million USD | -303708.953% |
| HST Global, Inc. | 1526.00 USD | -488198589.384% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -753964.862% |
| Halberd Corporation | 10.13 Thousand USD | -73535701.007% |
| Enzolytics Inc. | 361.7 Million USD | -1959.656% |
| Agentix Corp. | 261.39 Thousand USD | -2849991.816% |
| Resverlogix Corp. | 8.11 Million USD | -91704.214% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -396619.279% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | -64.006% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -15517.609% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -1164574.763% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -32702204.552% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -83147.1% |
| AVAX Technologies, Inc. | 7.37 Million USD | -100886.22% |
| Zenith Capital Corp. | 7410.00 USD | -100538523.482% |
| Genscript Biotech Corporation | 3.38 Billion USD | -119.996% |
| Ember Therapeutics, Inc. | 184.00 USD | -4048865117.391% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -2314932.038% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -2850297.147% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -802725.981% |
| Kadimastem Ltd | 2.3 Million USD | -323235.648% |
| Helix BioMedix, Inc. | 3.02 Million USD | -246171.081% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -13048402.47% |
| LadRx Corporation | 2.3 Million USD | -322702.986% |
| Cell Source, Inc. | 195.17 Thousand USD | -3817020.371% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -2106674.278% |
| NovAccess Global Inc. | 62.24 Thousand USD | -11968014.638% |
| Affymax, Inc. | 7.44 Million USD | -99992.866% |
| Itoco Inc. | 1.4 Million USD | -532009.206% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -7788051.416% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -7028118.868% |
| Mobile Lads Corp. | 52.00 USD | -14326753746.154% |
| CytoDyn Inc. | 11.13 Million USD | -66799.353% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -5210648.958% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -41666074.497% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -1932577.685% |
| SYBLEU INC | 330.46 Thousand USD | -2254252.01% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -1819516.923% |
| International Stem Cell Corporation | 5.39 Million USD | -138117.291% |
| Bioxytran, Inc. | 137.63 Thousand USD | -5412585.45% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -49560.021% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -44835.834% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -9430168.354% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -861483.227% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -99007.516% |
| Neutra Corp. | 2851.00 USD | -261308633.778% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -22889.298% |
| PureTech Health plc | 693.97 Million USD | -973.516% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -92203.678% |
| IXICO plc | 15.84 Million USD | -46920.687% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -89853.055% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -7110.244% |
| CSL Limited | 38.02 Billion USD | 80.406% |
| Cellectis S.A. | 333.99 Million USD | -2130.548% |